We can all agree that our current clinical workflow is flawed, and improving it is much more complicated than it seems. 🫣 Luckily, at #HTF2022, we had a panel discussion featuring Jan Poleszczuk from CliniNote and his fellow panellists Jacob Guy Diemar, Nadine van Dongen, and Chad Franklin. These experts shared insights on ways our current workflow can be reframed for better efficiency and lower costs. Join us this year and hear even more discussions on similar topics ▶ healthtechforward.com
Health Tech Forward’s Post
More Relevant Posts
-
We can’t wait for PHUSE US Connect later this month! Stop by booth #27 and start a conversation with one of our Instem expert about how you can supercharge your clinical trial analytics. We have a number of speaking sessions and are hosting a few events during the conference as well, check them all out here: https://lnkd.in/eSF97mVm Can’t wait to see you there! #phuse #PHUSEUSConnect #clinicaltrialanalytics #clinicaldatamanagement
-
-
Autonomix CEO Brad Hauser on the positive topline results from our ongoing PoC clinical trial: "The data is highly compelling, and demonstrates the opportunity to fill an important unmet need for patients and their families." Watch the full webcast discussion here: https://bit.ly/4ee1Nfc
-
Dr. Bert Hartog, Janssen Inc. is currently moderating a panel that is addressing the current challenges sites are experiencing and what they need in order to help reduce the burden on investigators, coordinators, and patients. Panelists include; Joanne Monaghan, RN, CCRC, Boston Clinical Trials, Casey Orvin, CenExel, Debra Weinstein, Science 37, Shafaat Ali Khan, Eli Lilly and Company, and Tyler Bye, WCG. Learn more about this year's program here - https://lnkd.in/eN7th3q #clinicaltrials #clinicalresearch #conference #digitalhealthtech #patienttechnology #digitalinnovation #endpointdevelopment #clinicalmonitoring #clinicaldatamanagement #FDAguidance
-
So looking forward to this important panel discussion with inspiring leaders, three from Labcorp!
Attending Precision Medicine World Conference in Silicon Valley, California, on Jan. 24-26? Don't miss our panel discussion that will explore the impact of partnerships in enabling improved access, especially within underrepresented populations, and focus on the benefits of collaboration in driving innovative testing. This approach empowers patients and providers, leading to improved outcomes throughout care. #PMWC24
-
🎙️ Join us next month for an insightful webinar with Dr. Robert Moldwin! In this presentation, Dr. Moldwin will delve into the expectations and impact of clinical trials, which play a crucial role in enhancing treatment and quality of care for individuals with IC/BPS. 🔗Don’t miss out! Register here 👉ichelp.org/navigatingicbps #InterstitialCystitis #BladderPainSyndrome #ICBPS #Webinar #ClinicalTrials #ICResearch
-
-
🎙️Join us next month for an insightful webinar with Dr. Robert Moldwin! 🌟In this presentation, Dr. Moldwin will delve into the expectations and impact of clinical trials, which play a crucial role in enhancing treatment and quality of care for individuals with IC/BPS. 🔗Don’t miss out! Register here 👉ichelp.org/navigatingicbps #InterstitialCystitis #BladderPainSyndrome #ICBPS #Webinar #ClinicalTrials #ICResearch
-
-
📢 Exciting News: Introducing Together4RD’s newly published Position Statement on collaboration between ERNs and industry! 🌟 We are delighted to share Together4RD’s position statement, which delves into a critical topic: the untapped potential of European Reference Networks (ERNs) in addressing the unmet needs of people living with a rare disease. 💪 Title: Together4RD Position Statement on Collaboration between European Reference Networks and Industry 🔗 Find the publication here: https://lnkd.in/epgN5UZr Despite the remarkable strides that ERNs have made in connecting medical professionals, researchers, and patients across Europe, we believe there is so much more we can achieve. Currently, ERNs are not fulfilling their full potential in research, largely due to lack of resources and support, and the lack of collaborations that harness relevant expertise, including with industry. Together4RD’s paper outlines strategic recommendations to address these challenges and enhance the efficacy of ERNs in the rare disease landscape. We firmly believe that by fostering stronger public-private partnerships and encouraging cross-sector collaboration, we can amplify the impact of ERNs and improve the lives of those who need it most. Find out more in our infographic below, and read the paper here: 🔗 Find the publication here: https://lnkd.in/epgN5UZr #Together4Rare #RareDiseases #ERNs #Collaboration
-
Vice President Sales & Marketing, Distributor Management | Medical Device Executive l Managing Director |P&L Driver | Medical Affairs
Curious about the iTind™ procedure? Dr. Hollowell provides real-world clinical experience and guidance on patient conversations in this on-demand #webinar. #BPH #iTind #OlympusPost
Real World Experience with iTind™ Procedure
post.olympusamerica.com
-
Patient-centric trial designs are the heart of successful clinical research, prioritizing participant convenience and accessibility. https://bit.ly/3HWCMpM Connect with Nooma to accelerate your site engagement initiatives
-
-
Patient-centric trial designs are the heart of successful clinical research, prioritizing participant convenience and accessibility. https://bit.ly/3HWCMpM Connect with Nooma to accelerate your site engagement initiatives
-
